This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Surgery  • Laser Surgery  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the article titled "Selective Laser Trabeculoplasty as Primary Treatment for Open-Angle Glaucoma" by Melamed et al.¹ We congratulate the authors for providing substantive evidence on the efficacy and safety of selective laser trabeculoplasty (SLT). We would like to point out, however, that this evidence regards only the first 3 postoperative months, since an increasing number of patients were lost to follow-up thereafter (Figure 2). Although the authors report a mean postoperative follow-up period of 11 months, this is slightly misleading, as only 38% of the treated eyes (17/45) were observed for 12 months.

We would also like to comment on the study’s methodology. The authors state that an intraocular pressure (IOP) of 23 mm Hg or greater in 2 consecutive measurements was 1 of the inclusion criteria. They do not mention if IOP was measured by applanation tonometry or another method, the interval between these 2 . . . [Full Text of this Article]

AUTHOR INFORMATION
Asimina Mataftsi, MD; Simon Horgan, MD

RELATED ARTICLE

Selective Laser Trabeculoplasty: Duration and Magnitude of Intraocular Pressure Reduction—Reply
Shlomo Melamed, Guy J. Ben Simon, and Hana Levkovitch-Verbin
Arch Ophthalmol. 2005;123(1):127.
EXTRACT | FULL TEXT